A post hoc analysis of the effect of viloxazine extended-release capsules on learning and school problems in children and adolescents with attention-deficit/hyperactivity disorder

Improvement in attention-deficit/hyperactivity disorder (ADHD) symptoms vs. placebo was reported in a series of pediatric clinical trials of viloxazine extended-release capsules (viloxazine ER; Qelbree™). This post hoc analysis of those studies evaluated the effect of viloxazine ER on learning and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Faraone, Stephen V., Gomeni, Roberto, Hull, Joseph T., Busse, Gregory D., Melyan, Zare, Rubin, Jonathan, Nasser, Azmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Contribution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038940/
https://www.ncbi.nlm.nih.gov/pubmed/34581911
http://dx.doi.org/10.1007/s00787-021-01877-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038940/
https://www.ncbi.nlm.nih.gov/pubmed/34581911
http://dx.doi.org/10.1007/s00787-021-01877-5

Ejemplares similares